J&J shares poised to hit record after earnings

Johnson & Johnson, the maker of Band-Aids and Tylenol, reported higher-than-expected quarterly earnings on Tuesday and nudged up its 2016 sales and earnings forecasts. The company's stock rose about 1.4 percent $112.50 in premarket trading, on track to open at a record high.